CA
NZ
UK
AU
IND
US
Patrick Fisher, President of Global Limb Recon at Orthofix Medical Inc. (NASDAQ:OFIX), filed a Form 4 on August 20, 2026, disclosing the sale of 1,295 shares of common stock on August 18, 2026, to satisfy tax withholding obligations connected to the settlement of restricted …
Ryan J. Martin, Senior Vice President Finance at Ameren Corporation, filed a Form 4 on August 20, 2026, reporting two open-market sales of Ameren common stock on August 18 and August 20, 2026.
Marcos Marcelo Mindlin, a director and 10% owner of Pampa Energy Inc., filed a Form 4 on August 20, 2026, disclosing two open-market purchases of common stock executed on August 18 and August 19, 2026.
Director David L. Mahoney filed a Form 4 with the SEC on August 20, 2026, disclosing the sale of 103,606 shares of Corcept Therapeutics Inc common stock on August 18, 2026, executed under a pre-established 10b5-1 trading plan.
A Form 4 filed on August 20, 2026 disclosed that Greg Elliot Sharenow, a Portfolio Manager of PIMCO Dynamic Income Strategy Fund, purchased 6,020 common shares on August 18, 2026 at a weighted average price of $21.7687 per share.
Director Erik Olsson filed a Form 4 with the SEC on August 20, 2026, disclosing the award of 639 restricted stock units of Herc Holdings Inc. (NYSE:HRI) on August 18, 2026.
Tamir Peres, SVP and Chief Information Officer of Herc Holdings Inc, filed a Form 4 on August 20, 2026, reporting the acquisition and partial tax-related disposition of common stock on August 18, 2026, tied to the vesting of performance stock units.
Jon Christianson, President of Palomar Holdings, Inc. (NASDAQ:PLMR), filed a Form 4 on August 20, 2026, disclosing transactions dated August 18, 2026, involving the vesting of restricted stock units and an automatic sale of shares to cover tax withholding obligations.
Jonathan Knutzen, Chief Risk Officer of Palomar Holdings, Inc. (NASDAQ:PLMR), filed a Form 4 on August 20, 2026, reporting the vesting of 612 restricted stock units and the automatic sale of 296 shares on August 18, 2026, to cover statutory tax withholding obligations.
A Form 4 filed on August 20, 2026, with the SEC reports that Brian JG Pereira, a director of ProKidney Corp., sold all of his directly and indirectly held Class A Common Stock across three consecutive trading days ending August 20, 2026.
Please wait processing your request...